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CHOLERA AND CLIMATE CHANGE: 
PURSUING PUBLIC HEALTH ADAPTATION STRATEGIES IN THE FACE OF SCIENTIFIC 
DEBATE 
 
Robin Kundis Craig* 
 
 
ABSTRACT 
 
 Climate change will affect the prevalence, distribution, and lethality of many 
diseases, from mosquito-borne diseases like malaria and dengue fever to directly 
infectious diseases like influenza to water-borne diseases like cholera and 
cryptosporidia. This Article focuses on one of the current scientific debates surrounding 
cholera and the implications of that debate for public health-related climate change 
adaptation strategies. 
 
 Since the 1970s, Rita Colwell and her co-researchers have been arguing a local 
reservoir hypothesis for cholera, emphasizing that river, estuarine, and coastal waters 
often contain more dormant forms of cholera attached to copepods, a form of 
zooplankton. Under this hypothesis, climatically driven increases in sea surface 
temperatures, sea surface levels, and phytoplankton production—such as during El Niño 
years or because of climate change—can then spur cholera outbreaks in vulnerable 
coastal communities. As such, the local reservoir hypothesis has immediate implications 
for climate change public health adaptation strategies.  
 
 In November 2017, however, two teams of scientists published genomic research in 
Science concluding that epidemic and pandemic cholera outbreaks in the Americas and 
Africa originate from Asia, suggesting that the local reservoir hypothesis needs 
modification. The two research articles also suggested a very different strategy for 
dealing with cholera in the Anthropocene—namely, genetic detection and intensely 
focused control efforts in Asia. 
 
 This Article examines in more detail this emerging scientific debate about cholera 
reservoirs and the ultimate source(s) of cholera outbreaks and epidemics. It then 
explores the implications of that debate for climate change public health adaptation 
strategies, suggesting simultaneously that the cholera debate is one concrete example of 
how identifying the stakes at issue in different climate change adaptation strategies can 
help communities and nations to choose appropriate adaptation strategies despite 
scientific uncertainty. 
                                                
* James I Farr Presidential Endowed Professor of Law, S.J. Quinney College of Law; affiliated faculty, 
Global Change and Sustainability Center; Board, University Water Center; University of Utah, Salt Lake 
City, UT. My thanks to Professor Victor Flatt for the invitation to participate in the University of Houston’s 
conference entitled “Climate Change Is Making Us Sick,” held December 7, 2017, in Houston. This 
research was made possible, in part, through generous support from the Albert and Elaine Borchard Fund 
for Faculty Excellence. I may be contacted at robin.craig@law.utah.edu. 
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INTRODUCTION: 
CLIMATE CHANGE, DISEASE, AND ADAPTATION 
 
 Climate change directly and indirectly changes human health vulnerabilities, 
including disease vulnerabilities. Indeed, in its 2014 Fifth Assessment, the 
Intergovernmental Panel on Climate Change (IPCC) devoted an entire chapter of its 
adaptation report to the human health impacts of climate change.1 It summarized that:  
 
The health of human populations is sensitive to shifts in weather patterns 
and other aspects of climate change (very high confidence). These effects 
occur directly, due to changes in temperature and precipitation and 
occurrence of heat waves, floods, droughts, and fires. Indirectly, health may 
be damaged by ecological disruptions brought on by climate change (crop 
failures, shifting patterns of disease vectors), or social responses to climate 
change (such as displacement of populations following prolonged 
drought).2 
 
As is true for climate change impacts generally, a community’s vulnerability to 
changing disease patterns depends on a complex mix of environmental and social factors.3 
For example, “[t]he background climate-related disease rate of a population is often the 
best single indicator of vulnerability to climate change—doubling of risk of disease in a 
low disease population has much less absolute impact than doubling of the disease when 
the background rate is high.”4 However, the changing climate itself and impacts on 
environmental attributes also matter: 
 
Climate extremes may promote the transmission of certain infectious 
diseases, and the vulnerability of populations to these diseases will depend 
on the baseline levels of pathogens and their vectors. In the USA, as one 
example, arboviral diseases such as dengue are rarely seen after flooding, 
compared with the experience in other parts of the Americas. The 
explanation lies in the scarcity of dengue (and other pathogenic viruses) 
circulating in the population, before the flooding. On the other hand, the 
high prevalence of HIV infection in many populations in sub-Saharan 
Africa will tend to multiply the health risks of climate change, due to the 
interactions between chronic ill health, poverty, extreme weather events, 
and undernutrition.5 
 
                                                
1 INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, 
AND VULNERABILITY 709-754 (2014) [hereinafter 2014 IPCC ADAPTATION REPORT]. 
2 Id. at 713. 
3 Id. at 717. 
4 Id. 
5 Id. (citations omitted). 
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Thus, as other researchers have emphasized, “Because most emerging disease agents are 
not new but are existing pathogens of animals or humans that have been given 
opportunities to infect new host populations, environmental and social changes—
especially those resulting from human activities which accelerate pathogen traffic—need 
to be defined.”6  
 
The IPCC emphasized that some of the major changes to human health that 
climate change is bringing involve alterations in food-borne, water-borne, and vector-
borne disease patterns.7 As such, any community’s climate change adaptation strategy 
should address expected changes in these disease risks, which in turn will often depend 
on climate change’s particular environmental impacts in and around that community. For 
example, vector-borne diseases like malaria, dengue fever, and tick-borne encephalitis, 
which are spread through insect vectors such as mosquitoes and ticks, often have complex 
relationships to changes in temperature and rainfall.8 Thus, in malaria-prone regions 
where climate change is pushing temperatures past mosquitoes’ maximum tolerance, 
malaria may actually decrease (although heat-related health problems will increase); in 
contrast, malaria is likely to increase in regions that historically have existed toward the 
lower end of mosquitoes’ temperature tolerance.9 Nevertheless, globally, climate change 
will probably increase significantly the number of people at risk for contracting malaria 
and increase the number of areas where dengue fever can exist.10 
 
                                                
6 Rita R. Colwell, Global Climate and Infectious Disease: The Cholera Paradigm, 274 SCIENCE 2025, 2025 
(20 Dec. 1996). 
7 2014 IPCC ADAPTATION REPORT, supra note 1, at 713. 
8 Id. at 722-25. 
9 Id. at 722 (citation omitted). These variable impacts become more pronounced at more extreme increases 
in global average temperature: 
 
Substantial warming in higher-latitude regions will open up new terrain for some infectious 
diseases that are limited at present by low temperature boundaries, as already evidenced by 
the northward extensions in Canada and Scandinavia of tick populations, the vectors for 
Lyme disease and tick-borne encephalitis. On the other hand, the emergence of new 
temperature regimes that exceed optimal conditions for vector and host species will reduce 
the potential for infectious disease transmission and, with high enough temperature rise, 
may eventually eliminate some infectious diseases that exist at present close to their upper 
tolerable temperature limits. For example, adults of two malaria-transmitting mosquito 
species are unable to survive temperatures much above 40°C in laboratory experiments, 
although in the external world they may seek out tolerable microclimates. Reproduction of 
the malaria parasite within the mosquito is impaired at lesser raised temperatures. Larval 
development of Aedes albopictus, an Asian mosquito vector of dengue and chikungunya, 
also does not occur at or above 40°C. 
 
Id. at 736 (citations omitted). 
10 Id. at 725-26. 
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Cholera, in turn, is a water-borne disease and “may be transmitted by drinking 
water or by environmental exposure in seawater and seafood . . . .”11 The IPCC noted in 
2014 that outbreaks of cholera and infections by related Vibrio species appear to be linked 
to temperature and rainfall changes in the relevant environment: 
 
Risk of infection is influenced by temperature, precipitation, and 
accompanying changes in salinity due to freshwater runoff, addition of 
organic carbon or other nutrients, or changes in pH. These factors all affect 
the spatial and temporal range of the organism and also influence exposure 
routes (e.g., direct contact or via seafood). In countries with endemic 
cholera, there appears to be a robust relationship between temperature and 
the disease. In addition, heavy rainfall promotes the transmission of 
pathogens when there is not secure disposal of fecal waste. An unequivocal 
positive relationship between Vibrio numbers and sea surface temperature 
in the North Sea has been established by DNA analyses of formalin-fixed 
samples collected over a 44-year period. Cholera outbreaks have been 
linked to variations in temperature and rainfall, and other variables 
including sea and river levels, sea chlorophyll and cyanobacteria contents, 
and Indian Ocean Dipole (IOD) and El Niño Southern Oscillation (ENSO) 
event.12 
 
While the IPCC offered no specific projections for cholera incidence in the future, its 
discussion nevertheless suggested that cholera outbreaks may be more likely as 
temperatures increase and heavy rainfall events become more likely. 
 
At a very basic level, what climate change means for future disease risk, including 
cholera, in a specific community depends on a number of variables, one of the most basic 
of which is disease etiology—that is, disease causation, especially in terms of where 
outbreaks actually come from and how they arise. Scientific debates over this etiology, 
and hence the disease’s relationship to climate change, bring into sharp focus one of the 
most pervasive impediments to the process of identifying and pursuing public health 
climate change adaptation strategies: scientific uncertainty regarding what climate change 
actually means for a given community’s or population’s disease vulnerability. Recent 
discoveries about cholera’s etiology, at least for some outbreaks, have brought this 
scientific uncertainty squarely into the realm of identifying cholera climate change 
adaptation strategies. 
 
This Article examines how nations should be thinking about cholera adaptation in 
light of a recently sharpened and profound scientific disagreement regarding where 
cholera epidemics and pandemics come from. Dr. Rita Colwell and her colleagues have 
                                                
11 Id. at 726. 
12 Id. 
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been pursuing a local reservoir hypothesis for cholera since the 1970s, based on 
discoveries that the cholera bacterium, Vibrio cholera, exists in local lakes, estuaries, and 
coastal waters in conjunction with copepods, a common form of zooplankton. Under this 
hypothesis, changes in climatic conditions can play a direct role in cholera outbreaks, 
putting cholera prevention squarely within the subject matter of climate change 
adaptation strategies. Two very recent papers in Science, in contrast, use genomic 
analyses to trace all recent cholera epidemics to Asia, suggesting very different strategies 
for dealing with cholera and a substantially reduced need for public health climate change 
adaptation strategies. 
 
 This Article thus examines cholera as a case study example of the climate change 
adaptation/scientific uncertainty conundrum. Part I presents a brief history of humanity’s 
interactions with cholera, especially the seven pandemics that have ravaged the world 
since the early 19th century. Part II then explains the local reservoir hypothesis of cholera 
outbreaks, emphasizing how researchers working under this hypothesis have identified 
environmental changes related to climate variability as both important causes and 
predictors of cholera outbreaks. Part III, in turn, examines the new “Asia origin” 
hypothesis and its implications for predicting and managing cholera—including the 
renewed hope that cholera could be eradicated.  
 
In Part IV, this Article examines the issue of public health climate change 
adaptation strategies for cholera in light of the ongoing scientific debate over the disease’s 
etiology, especially debates regarding the importance of climatic variation to cholera 
outbreaks. After more specifically examining the stakes of the scientific debate over 
cholera for public health measures and surveying existing strategies for dealing with 
scientific uncertainty in climate change adaptation planning, it turns to four on-the-
ground cholera prevention and treatment approaches and their places within public health 
climate change adaptation policies: early warning systems for cholera outbreaks; 
improved drinking water treatment and sanitation; investment in a cholera vaccine; and 
efforts to eliminate cholera by eliminating its sources in Asia—a strategy that necessarily 
assumes that the new science is wholly and exclusively correct. The Article concludes 
that, in a world of limited resources, multi-benefit adaptation strategies such as investing 
in improved drinking water and sanitation should probably take first priority in most 
countries, although it acknowledges that country-specific exigencies and priorities may 
justify (or allow) investment in disease-specific public health strategies such as the 
cholera vaccine. 
 
 
I. A BRIEF HISTORY OF CHOLERA AS A HUMAN DISEASE 
 
A. A Basic Overview of Cholera 
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Cholera appears to have a relatively long relationship with humanity. “There are 
descriptions of a disease resembling cholera in Sushruta Samshita from India, written in 
Sanskrit -500 to 400 B.C. Historical records tracing back 2000 years, in both Greek and 
Sanskrit, describe diseases similar to cholera.”13 The original reservoir of the cholera 
bacterium, Vibrio cholera, was the Ganges River delta in India.14 
 
Exposure to the cholera bacterium through contaminated drinking water or 
shellfish leads to infection of the small intestine and diarrhea.15 Most infected people 
display only mild symptoms and readily recover with no or mild treatment, although their 
feces can still spread the bacterium and disease for one to ten days after infection.16 
However, a minority of infected individuals “develop acute watery diarrhoea with severe 
dehydration. This can lead to death if left untreated.”17  
 
Scientists learned how to control the spread of cholera before they pinned down 
its actual cause. In 1854, during the third global cholera pandemic (see below), 
 
British physician John Snow succeeded in identifying contaminated 
water as the transmitter of the disease, a breakthrough in eventually bringing 
it under control. 
 
Snow carefully mapped the cases of cholera in the Soho area in 
London and traced the source to a water pump. After convincing officials 
to remove the pump handle, the number of cholera cases in the area 
immediately declined.18 
 
John Snow’s discovery remains critically important to cholera prevention even today. As 
the World Health Organization (WHO) emphasizes, “[p]rovision of safe water and 
sanitation is critical to control the transmission of cholera . . . .”19 
 
                                                
13 Colwell, supra note 6, at 2025. 
14 World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ 
(as updated Dec. 2017). 
15 Id.; D. Lippi & E. Gotuzzo, The greatest steps toward the discovery of Vibrio cholerae, 20 CLINCICAL 
MICROBIOLOGY & INFECTION 191, 191 (2014). 
16 World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ 
(as updated Dec. 2017). 
17 Id. 
18 CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century, 
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010). For a longer 
description of Snow’s investigation and discovery, see Lippi & Gotuzzo, supra note 15, at 192. 
19 CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century, 
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010). See also Lippi 
& Gotuzzo, supra note 15, at 191 (noting that epidemic cholera “is extremely contagious in communities 
without adequate sanitation.”). 
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 Connecting cholera to the Vibrio cholera bacterium, however, took a little longer. 
Filippo Pacini actually discovered this bacterium in 1854, the same year as John Snow’s 
epidemiological discovery.20 However, the prevailing theory of disease at the time, the 
miasmal theory of disease, provided no scientific context in which to connect the 
bacterium to cholera.21 However, the scientific transition to the germ theory of disease in 
the later 19th century allowed Robert Koch to connect the bacterium to the disease when 
he rediscovered Vibrio cholerae in 1883.22 Even then, however, skepticism over the role 
of V. cholerae in causing cholera persisted until 1959, when Sambhu Nath De discovered 
the bacterium’s toxin and completed the explanation of how it could cause diarrhea.23 
 
 Cholera disease occurs in three forms: endemic outbreaks, regional epidemics, 
and global pandemics. As WHO notes, “[c]holera is now endemic in many countries,” 
and “[a] cholera-endemic area is an area where confirmed cholera cases were detected 
during the last 3 years with evidence of local transmission (meaning the cases are not 
imported from elsewhere).”24 Therefore, as Parts II and III will discuss in more detail, 
local reservoirs of the cholera bacterium probably remain critical sources of endemic 
cholera outbreaks, which also tend to be far less lethal than the epidemic and pandemic 
versions. Cholera epidemics, in turn, are a significant increase, often sudden, in cholera 
cases in a specific area.25 “[E]pidemic cholera is an acute, painful and often lethal disease” 
that can lead to death from dehydration in a few hours.26 Major cholera epidemics 
continue to occur in South America and Africa.27 In addition, social unrest and war can 
foster cholera epidemics,28 as occurred in Yemen in 2017.29  
 
                                                
20 Lippi & Gotuzzo, supra note 15, at 191.  
21 Id. See also id. at 193 (“Although Pacini had discovered the vibrion, his cholera data were ignored by the 
scientific community and contradicted by influential physicians, who believed in the miasmatic theory, 
influenced by the localist/contagionist theory of the leading German scientist Max von Pettenkoffer, who 
considered cholera to be an airborne disease, caused by a combination of three factors: a germ, the local 
and seasonal conditions, and a constitutional predisposition to infection” (citation omitted)). 
22 Id. at 191, 193-94. 
23 Id. at 194; S.N. De, Enterotoxicity of bacteria-free culture filtrate of Vibrio cholerae, 183 NATURE 1533–
1534 (1959). 
24 World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ 
(as updated Dec. 2017). 
25 See Centers for Disease Control and Prevention, Epidemic Disease Occurrence, 
https://www.cdc.gov/ophss/csels/dsepd/ss1978/lesson1/section11.html (last updated May 18, 2012) 
(“Epidemic refers to an increase, often sudden, in the number of cases of a disease above what is normally 
expected in that population in that area.”). 
26 Lippi & Gotuzzo, supra note 15, at 191. 
27 Colwell, supra note 6, at 2026. 
28 World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ 
(as updated Dec. 2017). 
29 Cholera outbreaks began in Yemen in April 2017 and, by August 2017, there were over 500,000 
suspected cholera cases in that country, including almost 2000 deaths. World Health Organization, Cholera 
count reaches 500 000 in Yemen, http://www.who.int/mediacentre/news/releases/2017/cholera-yemen-
mark/en/ (14 Aug. 2017). 
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Finally, WHO defines a pandemic to be “the worldwide spread of a new 
disease.”30 Seven cholera pandemics have occurred, 31 as the next section explains in more 
detail. 
 
B. The Seven Cholera Pandemics 
 
While cholera has been a human disease for over two millennia, cholera 
pandemics are relatively new and date to 1817.32 Each cholera pandemic represents the 
global spread of a new infectious variant of the V. cholerae bacterium, and cholera 
bacteria have a wide range of genetic variations33—one reason why genomic studies like 
those published in 2017 can be revealing. All recent cholera outbreaks have been caused 
by the toxin-producing V. cholerae O1 serogroup.34 Within this serogroup, cholera exists 
in two biotypes, classical and El Tor, and both biotypes are further classified into two 
serotypes, Ogawa and Inaba.35 Classical strains of V. cholera O1 probably caused the first 
six cholera pandemics, but El Tor strains are responsible for the seventh.36 “Compared 
with the classical strains, El Tor persists for longer in the environment, causes more 
asymptomatic cases and is shed more extensively in excreta, even in asymptomatic 
cases.”37 
 
The first cholera pandemic was the relatively limited pandemic from 1817 to 
1823, which was “related to the two wars—the Oman War and the war between Persia 
                                                
30 World Health Organization, What is a pandemic?, 
http://www.who.int/csr/disease/swineflu/frequently_asked_questions/pandemic/en/ (24 Feb. 2010). 
31 World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ 
(as updated Dec. 2017). 
32 Colwell, supra note 6, at 2016. 
33 World Health Organization, Cholera vaccines: WHO position paper, 85:13 WEEKLY EPIDEMIOLOGICAL 
RECORD 117, 119 (2010) (noting that there are more than 200 serogroups of Vibrio cholerae), available at 
http://www.who.int/wer/2010/wer8513.pdf?ua=1 [hereinafter 2010 WHO Cholera Vaccines Paper]. 
34 As WHO further explains: 
 
There are many serogroups of V. cholerae, but only two—O1 and O139—cause outbreaks. 
V. cholerae O1 has caused all recent outbreaks. V. cholerae O139—first identified in 
Bangladesh in 1992—caused outbreaks in the past, but recently has only been identified in 
sporadic cases. It has never been identified outside Asia. There is no difference in the 
illness caused by the two serogroups. 
 
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ (as 
updated Dec. 2017). For a more detailed discussion of the various types of V. cholera and their role in 
human disease, see 2010 WHO Cholera Vaccines Paper, supra note 33, at 119. 
35 2010 WHO Cholera Vaccines Paper, supra note 33, at 119. 
36 Id. 
37 Id. See also Colwell, supra note 6, at 2026 (“A new biovar or biotype of Vibrio cholerae caused the 
current pandemic—the El Tor biotype of V. cholerae 01, which emerged in Celebes, Indonesia, in 1961. 
The disease caused by this organism is usually not as severe as that of the classical biotype.”).  
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and Turkey.”38 The pandemic “originated in the Ganges River delta in India,” breaking 
out near Calcutta and then spreading through the rest of the country. By the early 1820s, 
“colonization and trade had carried the disease to Southeast Asia, central Asia, the Middle 
East, eastern Africa, and the Mediterranean coast.”39 It is difficult to know for certain 
how many people died in this first pandemic, “but based on the 10,000 recorded deaths 
among British troops, researchers estimate that hundreds of thousands across India 
succumbed to the disease. In 1820, 100,000 people died on the Indonesian island of Java 
alone. By 1823, cholera had disappeared from most of the world, except around the Bay 
of Bengal.”40 
 
The second, more widespread, pandemic of 1829 to 184941 or 185142 is sometimes 
said to have begun in Russia43 but more likely began in India.44 However, if the latter, it 
“reached Russia by 1830 before continuing into Finland and Poland. A two-year outbreak 
began in England in October 1831 and claimed 22,000 lives.”45 Irish immigrants fleeing 
the potato famine brought the disease to North America in the summer of 1832, leading 
to 1,220 deaths in Montreal, Canada, and 1000 more across Quebec.46 From there, “[t]he 
disease then entered the U.S. through Detroit and New York, and reached Latin America 
by 1833. Another outbreak across England and Wales began in 1848, killing 52,000 over 
two years.”47  
 
The third pandemic, generally considered the most deadly of the seven, occurred 
from 1852 to 1859.48 Like all but the last of the cholera pandemics, it began in India, but 
it then spread to Asia, Europe, North America, and Africa.49 “In 1854, the worst year, 
23,000 died in Britain alone,”50 even as John Snow was completing his pioneering 
epidemiological work on cholera.  
 
The fourth cholera pandemic occurred from 1863 to 1879. It “began in the Bengal 
region [of India] from which Indian Muslim pilgrims visiting Mecca spread the disease 
to the Middle East. From there it migrated to Europe, Africa and North America. At least 
                                                
38 Colwell, supra note 6, at 2026. 
39 CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century, 
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010). 
40 Id. 
41 Id. 
42 Colwell, supra note 6, at 2026.  
43 Id. 
44 CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century, 
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010). 
45 Id. 
46 Id. 
47 Id. 
48 Id. 
49 Id. 
50 Id. 
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30,000 of the 90,000 Mecca pilgrims fell victim to the disease.”51 Russia was also hard 
hit: In 1866, cholera killed 90,000 Russians.52 
 
The fifth pandemic lasted from 1881 to 1896. It “originated in the Bengal region 
of India and swept through Asia, Africa, South America and parts of France and 
Germany.”53 During this pandemic, 90,00 people in Japan died of the disease between 
1887 and 1889, while in Russia cholera killed 200,000 people between 1893 and 1894.54 
However, “[q]uarantine measures based on the findings of John Snow kept cholera out of 
Britain and the United States,” and Ukrainian Waldemar Haffkine produced the first 
cholera vaccine in 1892. The sixth pandemic occurred from 1899 to 1923 (some sources 
say 1932) and “killed more than 800,000 in India before moving into the Middle East, 
northern Africa, Russia and parts of Europe.”55  
 
We are still living with the seventh cholera pandemic, which started in Makassar, 
Sulawesi, Indonesia, in 1961 and spread to six continents,56 reaching South Asia in 1963, 
Africa in 1970, Latin America in 1991, and the Caribbean (Haiti) in 2010.57 This 
pandemic most affects Africa, although “little is known about the propagation routes of 
cholera in this region.”58 In addition, “in 1991, 100 years after cholera was vanquished 
from South America, there was an outbreak in Peru that spread across the continent, 
killing 10,000 people. It was a similar strain to the seventh pandemic that petered out 
more than a decade earlier.”59  
 
C. The Global Health Burden of Cholera 
 
Researchers currently estimate that, “every year, there are roughly 1.3 to 4.0 
million cases, and 21 000 to 143 000 deaths worldwide due to cholera.”60 According to 
WHO, “Cholera remains a global threat to public health and an indicator of inequity and 
lack of social development.”61  
                                                
51 Id. 
52 Id. 
53 Id. 
54 Id. 
55 Id. 
56 Dalong Hu, et al., Origins of the current seventh cholera pandemic, 113:48 PNAS E7730, E7730 (Nov. 
29, 2016); Colwell, supra note 6, at 2026; World Health Organization, Cholera Fact Sheet, 
http://www.who.int/mediacentre/factsheets/fs107/en/ (as updated Dec. 2017). 
57 François Xavier Weill, et al., Genomic history of the seventh pandemic of cholera in Africa, 358 SCIENCE 
785, 785 (10 Nov. 2017). 
58 Id. 
59 CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century, 
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010). 
60 World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ 
(as updated Dec. 2017); Weill et al., supra note 57, at 785. 
61 World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ 
(as updated Dec. 2017). 
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In 2010, WHO projected that cholera could become even more problematic in the 
future, based in part on changing climatic conditions but also because of changes in the 
disease itself: 
 
Concerns about cholera have been heightened by the emergence of new, 
apparently more virulent, strains of V. cholerae O1 that now predominate 
in parts of Africa and Asia, as well as by the unpredictable emergence and 
spread of antibiotic-resistant strains. Also, there is a potential for increases 
in cholera outbreaks resulting from rising sea levels and increases in water 
temperature, since brackish water and estuaries are natural reservoirs of V. 
cholerae.62 
 
Given this latter concern, the connections between a changing climate and its impacts 
and future cholera outbreaks, epidemics, and pandemics indicate that cholera prevention 
and control should be a component of many nations’ climate change adaptation 
strategies. However, developing science has recently made the exact nature of those 
connections between climate and disease, especially for countries not near the Bay of 
Bengal, more problematic. The next two Parts discuss these contrasting hypotheses 
regarding cholera etiology. 
 
 
II. THE LOCAL RESERVOIR HYPOTHESIS AND CLIMATE CHANGE: 
CHOLERA, COPEPODS, AND WARMING WATERS 
 
 The history of cholera pandemics presented in Part I notes that the first six 
originated in India, while the last originated in Indonesia. India and Indonesia are two of 
the that surround the Bay of Bengal; the others include Bangladesh, Myanmar (Burma), 
and Malaysia (see Figure 1). Given this history of cholera epidemics, it is perhaps 
unsurprising that researchers have focused considerable energy on the role of the Bay of 
Bengal—and changes in coastal environments more generally—in the emergence of 
cholera outbreaks, epidemics, and pandemics. 
 
                                                
62 2010 WHO Cholera Vaccines Paper, supra note 33, at 119. 
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Figure 1: The Bay of Bengal and Surrounding Countries. This region has been the focus of research 
regarding the local reservoir hypothesis for cholera; the region has also been the starting point of all seven 
cholera pandemics. Map courtesy of Quora, https://www.quora.com/about/tos and 
https://qph.ec.quoracdn.net/main-qimg-e0417b691aed15d5e57a32c2f07d2890-c, and used in conformity 
with its re-posting policies. 
 
An environmental theory of cholera outbreaks pre-dated the 20th century. For 
example, Robert Koch offered such a hypothesis in the late 19th century but could not 
prove it “because of the ability of Vibrio cholerae, the causative agent of cholera, to enter 
a dormant phase between epidemics.”63 Beginning in the 1960s, however, Dr. Rita R. 
Colwell has spent decades working on the origins of cholera outbreaks and pandemics, 
focusing on local reservoirs and triggering environmental conditions. In 1996 in Science, 
she reported that cholera bacteria can survive in dormant states in coastal and marine 
waters. Specifically, “[a]ll Vibrio spp. that are pathogenic are adapted to salinities 
between 5 per mil and 30 per mil. Salinities favorable for growth of V. cholerae are found 
primarily in inland coastal areas and estuaries, but the bacterium thrives in seawater as 
well.”64 Cholera bacteria can survive in a dormant and non-infectious state in association 
with copepods, a form of small marine zooplankton, “but apparently can be resuscitated 
by heat shock.”65 In addition: 
 
                                                
63 Rita R. Colwell & A. Huq, Global microbial ecology: biogeography and diversity of Vibrios as a model, 
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The association of V. cholerae with zooplankton has proven to be a key 
factor in deciphering the global nature of cholera epidemics. V. cholerae 
preferentially attaches to chitinaceous plankton, for example, copepods, and 
can be detected in zooplankton in cholera endemic regions. Ocean currents 
sweeping along coastal areas thereby translocate plankton and their 
bacterial passengers.66 
 
Thus, according to Colwell, the sea and changes to the sea play an important 
environmental role in cholera outbreaks and pandemics, although of course “poor 
sanitation, lack of hygiene, and crowded living conditions” also play important roles in 
the disease’s spread.67 Nevertheless, “[t]he history of cholera reveals a remarkably strong 
association with the sea. The great pandemics followed coastlines of the world oceans.”68 
 
 Continuing research indicated that the release of dormant cholera bacteria from 
copepods was linked to algal blooms (on which the copepods feed), changing sea surface 
temperatures, and changing sea surface heights.69 All of these tend to occur during El 
Niño events, and research published in 1999 connected cholera outbreaks in Peru to the 
1997-1998 El Niño event.70 As such, the researchers concluded, advanced computational 
power in combination with increased interdisciplinary understanding of the role of 
copepods in cholera transmission would allow public health officials to take proactive 
approaches controlling cholera outbreaks, not just reactive.71 
 
 In 2008, Colwell and a large team of researchers published a more comprehensive 
assessment of the environmental factors associated with cholera epidemics in 
Proceedings of the National Academy of Sciences (PNAS).72 As they noted, “Before the 
late 1970s, transmission of cholera was believed to occur exclusively by person-to-person 
contact, with epidemics initiated by contaminated water and food.”73 However, “[i]t is 
now recognized that V. cholerae is a component of coastal and estuarine microbial 
ecosystems, with the copepod species of zooplankton that comprise the aquatic fauna of 
rivers, bays, estuaries and the open ocean serving as host for the bacterium.”74 Copepods 
act as a vector for the disease and can each contain up to 100,000 cholera bacteria cells.75 
As a result, ingestion of water containing even a few of these copepods “can initiate the 
disease,” which “was demonstrated in a study showing that the number of cholera cases 
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in Bangladeshi villages was significantly reduced when a simple filtration method that 
effectively removed the plankton and particulate matter was used to treat drinking 
water.”76 
 
 Research continued to show that copepod populations in the Bay of Bengal, and 
consequent cholera epidemics, are causally linked to environmental factors, including 
changes in sea surface temperatures and sea surface height.77 Later studies also 
emphasized the role of precipitation and chlorophyll concentrations in the sea, which is 
generally a function of algae growth and algal blooms.78 As a result, the researchers 
concluded, “the variables related to copepod population dynamics can serve as a proxy 
for the estimation of V. cholerae abundance in the environment.”79 
 
 Focusing on human cholera incidence in Kolkata, India, and Matlab, Bangladesh, 
these researchers noted that “[e]nvironmental factors were found to be statistically 
significant in [both] locations of the Indian continent in directly influencing the dynamics 
of cholera epidemics.”80 However, the effect of those environmental factors were “clearly 
different,” indicating that local variations are still important to cholera transmission.81 
For example, Matlab is farther away from the coast than Kolkata, and human exposure 
there appeared to be tied to tidal intrusion that carried increased numbers of copepods 
inland to rivers and streams, where residents were the directly exposed to V. cholerae in 
washing and drinking—as opposed to more direct coastal exposure in Kolkata.82 Matlab 
also showed a month’s lag behind Kolkata in cholera incidence after the relevant 
environmental indicators arose.83 
 
 Thus, local factors remain important to predictions of cholera incidence—and not 
just environmental factors. As the researchers noted,  
 
cholera epidemics involve a complex and critical interplay of intrinsic 
dynamics with extrinsic drivers. For example, cholera is no longer a disease 
threat for developed countries, including the United States, even though the 
presence of V. cholerae O1 in the waters of the Chesapeake Bay and coastal 
states of the Gulf of Mexico has long been known.84 
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Nevertheless, the researchers’ main points for public health purposes was that 
“environmental as well as epidemiological data need to be collected and compiled 
expediently to provide useful and reliable predictions of the onset, epidemics, and trends 
of cholera based on environmental variability” and that studies could improve cholera 
predictive capacities, giving public health researchers increasing and significant lead 
time to prepare a response and control strategy.85 
 
 As much of the research above indicates, Bangladesh is a cholera-endemic 
country.86 Benjamin A. Cash and his colleagues, expanding upon the local reservoir 
hypothesis and the postulated importance of climatic changes to cholera outbreaks and 
epidemics, noted a connection between the autumn incidence of cholera in Bangladesh 
and El Niño–Southern Oscillation (ENSO) events the previous winter—a potentially 
important climate connection in terms of predicting cholera outbreaks and epidemics.87 
ENSO affects both sea surface temperatures in the Bay of Bengal and rainfall in 
Bangladesh, and above-average rainfall in turn “provid[es] a plausible physical link 
between winter El Niño events and cholera incidence in Bangladesh through increased 
flooding and breakdowns in sanitation.”88 The researchers noted that “the El Tor strain 
of cholera replaced ‘the Classical’ strain in the environment during the mid-1970s” and 
hence that their research focused purely on the El Tor strain and acknowledged that “the 
two strains may respond differently to environmental drivers.”89 However, for the El Tor 
strain and recent incidences of cholera, they concluded that “that Bangladesh summer 
precipitation is generally higher following winter El Niño events when the warm [sea 
surface temperature] anomalies in the central tropical Pacific persist through the summer 
months,” establishing “a physical basis for the observed correlation between cholera 
incidence and ENSO.”90 Their results, moreover, potentially allowed for improved ability 
to predict cholera risk in Bangladesh, with initial predictions based on sea-surface 
temperatures and the state of ENSO in the winter and then modified through monitoring 
of sea surface temperature through the spring and summer.91 
 
 A year later, researchers showed that the Indian Ocean Dipole (IOD) is also 
relevant to cholera outbreaks in Bangladesh.92 As these researchers reported, the IOD: 
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is a climate mode arising from an ocean–atmosphere interaction that causes 
interannual climate variability in the tropical Indian Ocean. A positive IOD 
indicates SST [sea surface temperature] anomalies with warmer than usual 
SSTs over the western basin and cooler than usual SSTs in the eastern basin 
near Sumatra. A negative IOD occurs when the SST is anomalously warm 
in the eastern basin and anomalously cold in the western tropical Indian 
Ocean. Although the extent to which the IOD is independent of ENSO has 
been debated, there is growing evidence that this air–sea interaction is 
specific to the Indian Ocean.93 
 
The IOD can also affect sea level in the Bay of Bengal and regional climate, including 
monsoonal rainfall.94 Specifically, a negative IOD tends to raise sea level in the eastern 
equatorial region of the Indian Ocean and to increase flooding in Bangladesh.95  
 
As is true with other scientists working to elucidate the role of environmental 
factors in cholera outbreaks, the researchers here hoped to contribute to “the development 
of accurate early warning systems for cholera epidemics and aid in disease control.”96 
Using a time series analysis, they concluded that a positive IOD was associated with 
increased hospital visits for cholera 0-3 months later, as opposed to 8-11 months later for 
ENSO events.97 They hypothesized that the IOD’s effects on rainfall upstream was 
partially responsible for increased cholera incidence: 
 
Although the causal pathways are thought to be very complicated, high river 
levels/flooding are likely to be one of the important causal pathways. 
Increased river levels and flooding adversely affect water sources and 
sewerage systems and increase the exposure to water contaminated with V. 
cholerae. The possible link between flooding and cholera may also be 
associated with the growth and multiplication of V. cholerae, because 
flooding increases the level of insoluble iron, which in turn improves the 
survival rate of V. cholerae. It has also been suggested that flooding washes 
away the vibriophages that prey on V. cholerae, resulting in increased 
concentration of the bacterium in the water, although a recent simulation 
study did not support this hypothesis. It is unlikely that these possible 
pathways explain all cholera cases during the monsoon season, because the 
incidence of cholera often dips during monsoon flooding. This dip is 
thought to result from a reduction in salinity levels due to increased river 
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discharge, which reduces the survival of V. cholerae and decreases its 
concentration by monsoon rainfall (dilution effect).98 
 
Despite these complexities, however, the researchers concluded that their findings 
“suggest that Indian Ocean [sea surface temperature] variability should be taken into 
account when building predictive models for cholera using ocean-climate data,” 
including the early warning system for cholera that WHO had proposed “based on 
climatic parameters.”99 
 
 As the references above to Peruvian cholera outbreaks indicate, the local reservoir 
(copepod) hypothesis has also been proposed for other locations. In 2009, Colwell and 
Guillaume Constantin de Magny published a more general proposal that cholera 
outbreaks are related to climate.100 Noting that cholera “is reemerging in many parts of 
the world in epidemic form, especially in tropical areas,” the two researchers emphasized 
that “V. cholerae is naturally present in the environment,” notably in rivers, estuaries, 
and coastal waters.101 As a result, they suggested, the same etiology probably applies in 
all coastal nations where cholera is endemic: “At present, the main geographical regions 
of cholera endemicity include coastal areas surrounding the Bay of Bengal, Bangladesh, 
the Indian subcontinent, Africa, and coastal Latin America. In these regions, the same 
physical or environmental drivers most likely explain the patterns of disease.”102 The 
theory is relevant even to the United States, where cholera had gradually disappeared in 
the early 1900s because of improved sanitation and drinking water treatment.103 The 
United States is not entirely free of cholera, and “its first reappearance in the twentieth 
century [was] reported in 1973 in Texas. Since then, sporadic cases are reported each 
year in the United States, some of which have been confirmed as indigenous in origin.”104 
Chesapeake Bay is a proven reservoir of the V. cholera bacterium, and de Magny and 
Colwell developed a model to predict the presence and abundance of cholera bacteria in 
that Bay.105 While the model itself is not necessary to protect public health in the 
Chesapeake Bay region, it “illustrate[s] how an interdisciplinary research effort that 
includes microbiology, ecology and climatology can concretize academic research to a 
near-operational water-borne pathogen forecasting system.”106 
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 The linking of cholera outbreaks and epidemics to environmental factors—
especially factors such as precipitation, sea surface temperature, and sea surface height—
fairly directly makes continued control of cholera a climate change adaptation issue. 
Indeed, researchers in this field clearly recognize the climate change connection. For 
example, de Magny and Colwell pointed out in 2009 that: 
 
The relationship between human health and climate is not a new concept, 
but in the existing context of global change, when most scientists now agree 
that our climate is changing, there is an increasing need to understand the 
potential outcome of such changes on human health. This can be achieved 
by considering how systems interact. With few exceptions, zoonotic and 
vector-borne diseases are readily understood as having links with the natural 
environment, and cholera is one of the best examples to illustrate this 
biocomplexity.107 
 
This research also informed the IPCC’s conclusions about the links between climate 
change and human disease. As such, studies of the links between environmental factors 
and cholera incidence “provide a foundation on which to build a predictive capacity for 
cholera epidemics, hence, an early warning system for enhancing public health measures, 
especially for developing countries and areas of the world undergoing social disruption 
or climate change.”108  
 
 
III. THE ASIAN DISPERSION HYPOTHESIS: IS CLIMATE REALLY RELEVANT? 
 
 As noted, although much of the research supporting the local reservoir/copepod 
hypothesis regarding cholera etiology has occurred around the Bay of Bengal, researchers 
claim for it a broader application to cholera’s origins. However, two genomic studies 
recently published in Science call into question the ubiquity of the local reservoir 
hypothesis, especially as pertains to cholera outbreaks in Africa and in Latin America. 
 
 Focusing on strains of the El Tor variety of the V. cholera bacterium, the Africa 
study109 identified two El Tor strains “known to have invaded Africa in 1970: one in West 
Africa (serotype Ogawa) and the other in East Africa (serotype Inaba).”110 The Ogawa 
bacteria in Africa were related to three Chinese variations and one Indian variation, while 
the Inaba serotype appears to be a mutation of the Ogawa.111 Overall, the genomic 
analysis indicated that seventh-pandemic cholera that arrived in Africa in 1970 came from 
South or East Asia by way of Russia and the Middle East, arriving first in Angola and 
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then spreading to Mozambique and to Portugal and Europe as a result of Portuguese 
decolonialization wars and the deployment and rotation of Portuguese troops.112 
Moreover, the ten additional cholera introduction events between 1970 and 2008 all 
appear to have originated in South or East Asia, with seven events involving migration 
through the Middle East first and three arriving in Africa directly from Asia.113 From 
these introductions into West Africa and Eastern/Southern Africa, “[e]pidemic waves 
then propagated regionally, in some instances spreading to Central Africa, over periods 
of a few years to 28 years . . . .”114 The genomic study could also track the cholera 
bacterium’s acquisition of antibiotic resistance.115 
 
 Noting that their results are consistent with epidemiological studies of cholera in 
African countries, the researchers in the African study concluded that “the human-related 
factors play a much more important role in cholera dynamics in Africa than climatic and 
environmental factors.”116 Specifically, “[o]ur data do not suggest that aquatic 
environmental reservoirs are the primary source of epidemic cholera in Africa”; instead, 
“these results highlight the role that humans play in the long-term spread and maintenance 
of the pathogen, whether by direct (human-to-human) or indirect (pollution of the 
environment with feces from cholera patients) transmission.”117 
 
The Latin America study focused on the relationship “between local populations 
and globally circulating pandemic lineages of V. cholerae” in the Americas, noting that 
“pandemic cholera was absent from Latin America for 100 years.”118 It analyzed 252 
cholera isolates from 14 countries spanning 1974 to 2014, about two-thirds of which were 
seventh-pandemic El Tor varieties of cholera and about one-third of which were other 
varieties.119 The strains covered pre-epidemic, epidemic, and interepidemic periods, 
including the 1991 Peruvian epidemic and 2010 Haitian epidemic.120 They included both 
O1 and non-O1 V. cholerae, as well as samples from both clinical and environmental 
sources.121 
 
 The genomic analysis “revealed a marked diversity of V. cholerae lineages in this 
region.”122 The cholera samples from the 1991 Peruvian and 2010 Haitian epidemics 
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clustered in the seventh-pandemic El Tor lineages.123 Nevertheless, 11 cholera lineages 
were represented in the Latin American isolates, from classical V. cholerae found in 
Mexico in the mid-1990s to V. cholerae O1 local lineages to an Endemic Latin American 
lineage.124 “More than 30 additional isolates sampled across Latin America do not belong 
to any previously known lineage and comprise at least eight different serotypes . . . .”125  
 
Thus, a wide range of genetic variations exist in the cholera bacteria found in 
Latin America. Moreover, “[l]ocal V. cholerae O1 lineages in Latin America harbor a 
wide range of genetic determinants that are associated with pandemic disease,”126 and the 
discovery of classical lineages from Mexico dating from 1995 to 1997 demonstrated that 
this version of the infectious bacterium had not disappeared in the 1980s, as previously 
believed.127 
 
 Focusing on the seventh-pandemic El Tor lineage, however, the genomic research 
showed “that the Latin American cholera epidemics were the result of multiple 
intercontinental introductions . . . .”128 The strains of cholera in Latin America from the 
first introduction of cholera during the seventh pandemic were most directly related to 
strains from Western and Central Africa129; the strains from the second introduction were 
related to strains “in South and Southeast Asia, Western Asia (Lebanon) and Eastern 
Europe (Romania);130 and the strains from the third introduction were related to the 
Haitian sublineage.131 
 
 However, cholera in this part of the world is more complicated than just 
pandemics, and the researchers outlined “three distinct patterns of diarrheal disease 
within Latin America.”132 First, some cholera lineages cause “sporadic cases or limited 
outbreaks, in which secondary infections are rare or nonexistent.” While these cases are 
cholera, they are far more limited in number than those generated by pandemic strains.133 
“Second, lineages that occupy long-term environmental reservoirs (such as the Gulf Coast 
lineage) cause illness over longer periods of time and across larger geographic areas”; 
again, however, they are responsible for far fewer cases of cholera overall.134 Finally, the 
“[t]hird pattern, caused by pandemic V. cholerae, is visibly distinct. Pandemic lineages 
are responsible for massive, explosive epidemics that occur over short periods of time,” 
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causing 20,000 cases per week in Peru in 1991 to 250,000 cases over six months in Haiti 
in 2010.135  
 
Importantly, the third pattern cases—the ones that significantly burden the public 
health system—all arose (directly or indirectly) from strains of cholera bacteria that 
arrived from Asia.136 Thus, like the Africa study, the Latin American study downplayed 
the importance of local cholera reservoirs to the global cholera disease burden. 
 
 
IV. STRATEGIES FOR CHOLERA PREVENTION IN LIGHT OF SCIENTIFIC UNCERTAINTY 
AND CLIMATE CHANGE 
 
The debate over the etiology of cholera epidemics and pandemics provides a 
concrete example of a recurring issue in developing public health climate change 
adaptation strategies: the problem of scientific uncertainty. This Part looks first at the 
specific stakes for public health strategies of the cholera etiology debate, then reviews 
general approaches to climate change adaptation planning in the face of uncertainty. It 
then uses those approaches to assess four cholera-specific strategies: develop an early 
warning system; improve drinking water access and treatment and basic sanitation; invest 
in a cholera vaccine; and seek to control emerging cholera epidemics at their source.  
 
A. The Stakes of the Debate: Why Does Cholera’s Etiology Matter to a Public 
Health Climate Change Adaptation Strategy? 
 
Notably, neither of the two 2017 genomic studies of cholera study posits that 
Asia-derived cholera strains are the sole source of cholera infection. The authors of the 
Africa study specifically noted that their research does not exclude the possibility that 
other cholera strains cause sporadic disease on that continent.137 More decisively, the 
Latin American study explicitly found that there are different types and sources of cholera 
in Latin America, concluding that “[a]n appreciation of the differences between pandemic 
and local lineages should inform the design of disease control strategies in Latin 
America.”138 Nor does either study refute (and, by affirming a southern Asian origin for 
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many cholera pandemics, might in some ways affirm) the climate-related etiology of 
cholera epidemics in Bay of Bengal countries like India and Bangalesh. 
 
 Nevertheless, as the Latin American study emphasized, epidemic and pandemic 
strains of cholera impose a much greater global disease burden than the other types. As a 
result, an Asian origin hypothesis for these forms of cholera outbreaks has direct 
implications for where public health officials should focus their limited resources. Indeed, 
the Latin America researchers discussed the stakes at issue: 
 
[E]xploratory analyses have demonstrated since the 1970s that V. cholerae 
is an integral member of many coastal, estuarine, and brackish water 
ecosystems, as are other Vibrio species, in which it is often associated with 
copepods and zooplankton. Accordingly, a view of V. cholerae 
epidemiology emerged in the following decades, which posits that locally 
evolving, but globally distributed, V. cholerae populations are responsible 
for cholera outbreaks, which occur when climatic or environmental stimuli 
provide favorable bacterial growth conditions in these environs. This 
perception has had profound effects on all levels of global public health; 
cholera is now considered to be ineradicable because its etiological agent is 
ubiquitous in aquatic ecosystems.139 
 
The Asian origin hypothesis leads to different cholera public health strategies than 
the local reservoir hypothesis, particularly in terms of how to assemble early warning 
systems for developing cholera epidemics and pandemics and of what the eventual global 
health goal for cholera should be. With respect to early warning systems, such systems 
based on the local reservoir hypothesis focus on detecting relevant changes in 
environmental variables, such as sea surface temperature, sea surface height, and 
chlorophyll or phytoplankton concentrations. In contrast, under the Asian origin 
hypothesis, early warning systems take the form of genetic detection.140 As for the 
ultimate public health goals for cholera, the local reservoir hypothesis means that cholera 
can never be completely eliminated—only controlled and treated.141 In contrast, an Asian 
origin means that cholera—at least in its epidemic and pandemic forms—could be 
eradicated.142 Thus, the Asian origin hypothesis could lead the global public health 
community to invest considerably more into Asia-centric cholera research, perhaps at the 
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expense of learning more about complex cholera etiologies such as exist in Latin 
America. 
 
B. General Strategies for Planning Under Uncertainty 
 
So, where should public health officials concerned about cholera and its possible 
future under climate change invest their time, adaptation efforts, and limited funding? 
The costs of public health climate change adaptation strategies “may be considerable.”143 
As a result, few individual nations nor the international community at large are likely to 
be able to afford all-out, multi-stranded disease adaptation efforts. Under these 
circumstances, the stakes at issue in adaptation choices, as well as potential multiple 
benefits from certain choices, should become important factors in how the public health 
sector chooses to adapt to climate change. 
 
At the outset, public health-focused climate change adaptation strategies should 
reflect well-established public health principles and a proactive approach.144 One such 
principle is prevention, which can occur at three levels: 
 
Primary prevention aims to prevent the onset of injury or illness; clinical 
examples include immunization, smoking cessation efforts, and the use of 
bicycle helmets. Secondary prevention aims to diagnose disease early to 
control its advance and reduce the resulting health burden; clinical examples 
include screening for hypertension, hyperlipidemia, and breast cancer. 
Tertiary prevention occurs once disease is diagnosed; it aims to reduce 
morbidity, avoid complications, and restore function.145 
 
A second principle, and one directly related to uncertainty, is preparedness.146 New 
threats such as terrorist attacks and the reemergence of infectious diseases has made the 
study and anticipation of health impacts a revitalized central tenet of public health 
practice, and climate change fits easily within this practice.147 Third, “[r]isk 
management—systematic ongoing efforts to identify and reduce risks to health—is 
another relevant framework.”148 Co-benefits offer a fourth “important framework for 
public health action on climate change. Steps that address climate change frequently yield 
other health benefits, both direct and indirect.”149 A fifth consideration is economics: 
“Economic considerations are critical in public health planning. The mandate to 
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maximize health protection at the lowest short-term and long-term cost is highly relevant 
to climate change.”150 “Finally, ethical considerations guide public health attention to 
climate change.”151 
 
A number of general guidelines and procedures have already been proposed to 
alleviate the risk planning stagnation in the face of scientific uncertainty, particularly with 
respect to climate change. For example, scenario planning provides one method of 
extrapolating a variety of future conditions based on varied assumptions about climatic 
impacts and social and economic factors.152 “The central idea of scenario planning is to 
consider a variety of possible futures that include many of the important uncertainties in 
the system rather than to focus on the accurate prediction of a single outcome.”153   
 
Scenarios may encompass realistic projections of current trends, qualitative 
predictions, and quantitative models, but much of their value lies in 
incorporating both qualitative and quantitative understandings of the system 
and in stimulating people to evaluate and reassess their beliefs about the 
system. Useful scenarios incorporate imaginative speculation and a wide 
range of possibilities; those based only on what we currently know about 
the system have limited power because they do not help scenario users plan 
for the unpredictable.154 
 
“Scenario planning aims to enhance our ability to respond quickly and effectively to a 
wide range of futures, avoiding potential traps and benefiting from potential 
opportunities.”155 The scenarios themselves are form of storytelling about the future: 
“Scenarios should become brief narratives that link historical and present events with 
hypothetical future events. Within these storylines the internal assumptions of the 
scenario and the differences between stories must be clearly visible. To be plausible, each 
scenario should be clearly anchored in the past, with the future emerging from the past 
and present in a seamless way.”156 The goal of scenario planning is to enhance 
institutional and individual capacity to productively respond to future change: 
 
A successful scenario-planning effort should enhance the ability of people 
to cope with and take advantage of future change. Decisions can be made, 
policies changed, and management plans implemented to steer the system 
toward a more desirable future. New research or monitoring activities may 
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be initiated to increase understanding of key uncertainties, and they may 
stimulate the formation of new coalitions of stakeholder groups.157 
 
A related approach more specific to public health is vulnerability mapping.158 
Vulnerability mapping can reveal potentially increasing vulnerabilities for a number of 
climate change-related health impacts, including disease.159 For example, the IPCC has 
applauded a number of vulnerability mapping efforts in response to climate change: 
 
spatial modeling of geo-referenced climate and environmental information 
was used to identify characteristics of domestic malaria transmission in 
2009–2012 in Greece, to guide malaria control efforts. Mapping at regional 
and larger scales may be useful to guide adaptation actions. In Portugal, 
modeling of Lyme disease indicates that future conditions will be less 
favorable for disease transmission in the south, but more favorable in the 
center and northern parts of the country. This information can be used to 
modify surveillance programs before disease outbreaks occur.160 
 
Moreover, as the IPCC noted, vulnerability mapping can inform surveillance and early 
warning systems, another adaptation strategy that can mitigate uncertainty.161 
 
Once future possibilities are understood, a search for “no regrets” measures can 
become an effective means of starting a climate change adaptation strategy. “No regrets” 
measures are adaptation strategies that are a good idea under all or at least most future 
scenarios and generally offer current benefits, as well.162 “No regrets” strategies are often 
options that communities or nations should be pursuing anyway but that have been 
stymied for any of several reasons—“[m]any obstacles explain the current situation, 
including (i) financial and technology constraints, especially in poor countries; (ii) lack 
of information and transaction costs at the micro-level; and (iii) institutional and legal 
constraints.”163 Climate change adaptation can thus provide the impetus for overcoming 
these obstacles. For example, as Hurricane Harvey amply demonstrated in late August 
and early September 2017, toxic sites in the U.S. coastal zone pose both a current health 
and safety risk and a future vulnerability in light of sea-level rise and the expected 
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increasing numbers of increasingly violent coastal storms.164 As such, coastal cleanup 
efforts pursuant to the federal Comprehensive Environmental Response, Compensation, 
and Liability Act (CERCLA or Superfund)165 and parallel state laws qualifies as “no 
regrets” climate change adaptation strategies in the United States. 
 
“Second, it is wise to favour strategies that are reversible and flexible over 
irreversible choices. The aim is to keep as low as possible the cost of being wrong about 
future climate change.”166 For example, restrictive land use planning can be a helpful but 
also changeable legal adaptation strategy, allowing development patterns to reflect 
evolving understanding of climate change impacts in a community.167 
 
“Third, there are ‘safety margin’ strategies that reduce vulnerability at null or low 
costs.”168 Such strategies are often most relevant when communities or nations are 
investing in new infrastructure related to climate change impacts (for example, 
infrastructure to handle runoff or flooding), when building in additional capacity to 
handle the worst of expected impacts generally incurs relatively small marginal costs.169 
 
Institutional strategies are a fourth form of adaptation strategies.170 These 
strategies, often referred to as “soft” and “timing” strategies, are usually flexible and 
reversible, and they often take the form of ensuring that climate change risk assessment 
and planning occur more often and at different levels of governance (international, 
national, local).171 However, institutional strategies can also be financial, such as through 
insurance laws or funding schemes to promote certain behaviors or investments.172 
 
Finally, adaptation planning in the face of uncertainty requires that planners be 
cognizant of potentially conflicts and synergies among adaptation strategies.173 “For 
instance, an increased use of snow-making to compensate for shorter skiing seasons in 
mountain areas would have negative consequences for water availability and, e.g., 
agriculture. This example shows that adaptation strategies that look profitable when 
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considering only one sector may be sub-optimal at the macroeconomic scale because of 
negative externalities.”174 
 
C. The “Preparedness” Option: Early Warning Systems for Cholera Epidemics 
 
 From a public health perspective, cholera surveillance and early warning systems 
clearly serve a public health preparedness function. Most obviously, a few extra months 
of warning that a cholera epidemic is likely allow public health officials time to stockpile 
components for effective treatment—antibiotics, I.V. fluids, disinfectants, and so 
forth.175 Moreover, in light of improved vaccines,176 early warning systems could also 
allow many cases of cholera to be prevented. 
 
Notably, researchers working under both of the cholera etiology hypotheses are 
looking to develop an early warning system for cholera. However, the proposed systems 
are completely different. As several researchers working under the local reservoir 
hypothesis emphasize, the importance of an environmental theory of cholera etiology is 
that it allows scientists to develop predictive models, based on indicator environmental 
conditions, that in turn can provide warnings to public health officials regarding potential 
cholera outbreaks and epidemics.177 Climatic events to be monitored for include El Nino 
events,178 changes in the IOD,179 and more general environmental changes and climate 
change impacts.180  
 
In contrast, the early warning system under the Asian origin hypothesis consists 
of increased genetic testing. Specifically, “When a new cholera case appears, researchers 
can now sequence the bacterium to determine whether it belongs to the pandemic lineage 
from Asia. That could help pinpoint truly dangerous outbreaks that most warrant use of 
the limited vaccine stocks . . . .”181 
 
These two strategies appear to require contradictory investments into both 
research and public health capacity. What remains to be satisfactorily articulated, 
however, is whether scientists and public health officials should pursue both 
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approaches—i.e., whether the two types of early warning are in fact complementary and 
synergistic rather than contradictory, especially with respect to the Bay of Bengal and the 
countries that surround it. Until that issue can be resolved, it is probably worth pursuing 
both strategies, particularly in South Asia. Genetic composition is clearly relevant to 
cholera’s infectious characteristics and lethality; but, again, nothing in the two new 
genomic studies directly undermines the importance of the environmental factors to the 
emergence of cholera epidemics in South Asia—epidemics, if the genomic studies are 
correct, that can then spread to the rest of the world.  
 
D. The “No Regrets” Option: Improve Drinking Water Access and Treatment 
and Sanitation 
 
According to the IPCC’s 2014 report, climate change adaptation strategies for 
public health impact need to consider a variety of factors: 
 
The degree to which programs and measures will need modification to 
address additional pressures from climate change will depend on the current 
burden of ill health; the effectiveness of current interventions; projections 
of where, when, and how the health burden could change with climate 
change; the feasibility of implementing additional programs; other stressors 
that could increase or decrease resilience; and the social, economic, and 
political context for intervention.182 
 
Despite this complexity, however, “[t]he most effective measures to reduce vulnerability 
in the near term are programs that implement and improve basic public health measures 
such as provision of clean water and sanitation, secure essential health care including 
vaccination and child health services, increase capacity for disaster preparedness and 
response, and alleviate poverty (very high confidence).”183  Indeed, one of the IPCC’s 
five “take-home messages” about climate change adaptation and public health in 2014 
was that: 
 
In the immediate future, accelerating public health and medical 
interventions to reduce the present burden of disease, particularly diseases 
in poor countries related to climatic conditions, is the single most important 
step that can be taken to reduce the health impacts of climate change. 
Priority interventions include improved management of the environmental 
determinants of health (such as provision of water and sanitation), 
infectious disease surveillance, and strengthening the resilience of health 
systems to extreme weather events.184 
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As cholera researchers have observed, “Because infection results from ingesting 
contaminated water, cholera epidemics typically occur in regions with a limited or 
damaged infrastructure.”185 Many of the studies discussed above noted that cholera no 
longer occurs with any frequency in the United States and other developed countries 
because these countries have safe drinking water and their citizens practice good 
sanitation and hygiene—not because natural reservoirs of the V. cholerae bacterium are 
lacking.186 As WHO has emphasized repeatedly, improved sanitation and drinking water 
supplies are and should be the primary goal to address cholera.187 
 
Investments in basic sanitation—clean drinking water and human waste 
facilities—are “no regrets” public health climate change adaptation strategies because 
such infrastructure provides multiple benefits. The statistics for clean drinking water are 
somewhat encouraging: “89% of the world population used an improved drinking-water 
source by end of 2011,” meaning a source protected from contamination, especially 
contamination from feces.188 Nevertheless, “An estimated 768 million people did not use 
an improved source for drinking-water in 2011 and 185 million relied on surface water 
to meet their daily drinking-water needs.”189 Sanitation statistics are even more troubling. 
According to WHO, in 2015: 
 
• 2.3 billion people still do not have basic sanitation facilities such as 
toilets or latrines. 
• Of these, 892 million still defecate in the open, for example in street 
gutters, behind bushes or into open bodies of water. 
• At least 10% of the world’s population is thought to consume food 
irrigated by wastewater. 
• Poor sanitation is linked to transmission of diseases such as cholera, 
diarrhoea, dysentery, hepatitis A, typhoid and polio. 
• Inadequate sanitation is estimated to cause 280 000 diarrhoeal 
deaths annually and is a major factor in several neglected tropical 
diseases, including intestinal worms, schistosomiasis, and trachoma. 
Poor sanitation also contributes to malnutrition.190 
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In addition, the number of people lacking basic sanitation is projected to increase 
throughout the 21st century in concert with generally increasing populations, and various 
organizations project “that about 1.4 billion people will be without access to basic 
sanitation in 2050.”191 
 
 A large factor in nations’ failure to invest in the “no regrets” options of clean 
drinking water supply and waste sanitation is cost. In 2008, WHO calculated the cost of 
achieving the Millennium Development Goal for drinking water and sanitation—i.e., “to 
‘halve, by 2015, the proportion of people without sustainable access to safe drinking 
water and basic sanitation’.”192 It estimated the total cost of new services over the 
implementation period of 2005-2014 to be US$42 billion for drinking water and US$142 
billion for sanitation, while the cost of maintaining existing infrastructure would be an 
additional US$322 billion for water supply and US$216 billion for sanitation.193 
Combined, the total investment required amounted to about US$72 billion per year over 
the 10-year implementation period,194 and still, not all people would have safe drinking 
water and good sanitation at the end of it.  
 
Moreover, countries should also be ensuring that any new investment in drinking 
water and sanitation infrastructure includes a “safety margin” strategy that accounts for 
potentially worsening climate change impacts on water supplies and contaminating 
runoff. In places where drinking water supplies are becoming increasingly vulnerable or 
where extensive retrofitting may be required, however, this “safety margin” strategy 
could significantly increase the costs of implementing this first, best strategy for 
preventing water- and hygiene-related disease. 
 
E. The Prevention and Flexibility Option: The Cholera Vaccine 
 
Improved sanitation, clean drinking water, and internalized hygiene practices are, 
everyone agrees, the long-term best investment for preventing cholera—and would 
improve human health more generally in a wide variety of ways. However, as noted, 
drinking water and sewage treatment infrastructure are very expensive, requiring 
substantial governmental, international organization, or private company investment to 
build. In addition, such infrastructure investment also often comes off as, well, prosaic. 
Boring. Far more exciting and newsworthy—and funding-attracting—are new and 
effective treatments for an individual disease. Thus, for example, in February 2017, The 
New York Times waxed poetic about a new I.V. treatment protocol for cholera “so 
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effective that it saves 99.9 percent of all victims” of the disease and the new “effective 
cholera vaccine,” enough of which may soon be stockpiled “to begin routine vaccination 
is countries where the disease has a permanent foothold.”195 “The world finally has a 
vaccine that, with routine administration, could end one of history’s greatest scourges,” 
it concluded, although acknowledging that, “[w]ith 1.4 billion people at risk, the potential 
cost of vaccination in cholera-endemic countries is enormous.”196 
 
WHO has acknowledged the potential role of oral cholera vaccines in cholera 
prevention.197 As such, cholera vaccines are among the options available to nations 
pursuing cholera-specific public health climate change adaptation strategies. What 
exactly that role should be, however, is an important public health and climate change 
adaptation planning question, the exact answer to which is likely to vary according to the 
specific risks faced by and financial circumstances of individual nations and regions. 
 
In 2010, five different cholera vaccines existed: (1) Dukarol, an oral vaccine; (2) 
Shanchol, an oral vaccine; (3) mORCVAX, an oral vaccine; (4) CVD 103- HgR, an oral, 
live, attenuated single-dose vaccine that was not being produced at the time; and (5) an 
injectable vaccine prepared from strains of V. cholerae made inactive with phenol.198 In 
its 2010 position paper on these vaccines, WHO recommended against use of the 
injectable vaccine, “mainly because of its limited efficacy and short duration of 
protection.”199 
 
With regard to the three oral cholera vaccines that remained in production in 2010, 
Swedish researchers developed Dukoral and first licensed it in 1991, with over 60 
countries eventually approving the vaccine for use.200 Dukoral is used “primarily as a 
vaccine for travelers to cholera-endemic areas. However, it has also been used in crisis 
situations in Indonesia, Sudan and Uganda, and in a demonstration project in an endemic 
area of Mozambique.”201 The vaccine is relatively safe to take and was “tested in 
randomized placebo-controlled double-blind prelicensure efficacy trials in both 
Bangladesh and Peru”202 as well as in several other studies, including field trials.203 
Moreover, because the vaccine contains a recombinant cholera toxin B subunit, it also 
protects against ETEC infections.204 
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Shanchol and mORCVAX are so similar that WHO evaluates them together. 
“Unlike Dukoral, these vaccines do not contain the bacterial toxin B subunit and will 
therefore not protect against ETEC.”205 Researchers licensed the original ORCVAX 
vaccine in Vietnam in 1997, and “[f]rom 1998 to 2009, >20 million doses of this vaccine 
were administered to children in high-risk areas of Viet Nam, making ORCVAX the first 
oral cholera vaccine to be used primarily for endemic populations.”206 ORCVAX was 
reformulated in 2004 to meet WHO standards, and, “[f]ollowing successful phase II trials 
in India and Viet Nam, this vaccine was licensed in 2009 as mORCVAX in Viet Nam 
and as Shanchol in India; mORCVAX is currently intended for domestic use in Viet Nam, 
whereas Shanchol will be produced for Indian and international markets.”207 
 
WHO concluded in 2010 that all three oral vaccines are safe and provide short-
term (about two years) protection against cholera in endemic countries.208 The vaccines 
can also result in herd immunity if administered extensively in a given population, which 
provides cholera protection to infants and children too young to receive the vaccine.209 
Finally, while data were limited, cholera vaccine programs appeared to be cost-
effective.210 WHO concluded in 2010 that “[c]holera control should be a priority in areas 
where the disease is endemic” and that the oral vaccines “should be used in conjunction 
with other prevention and control strategies in areas where the disease is endemic and 
should be considered in areas at risk for outbreaks.”211 However, WHO cautioned, 
 
Vaccination should not disrupt the provision of other high-priority health 
interventions to control or prevent cholera outbreaks. Vaccines provide a 
short-term effect that can be implemented to bring about an immediate 
response while the longer term interventions of improving water and 
sanitation, which involve large investments, are put into place.212 
 
Moreover, “[i]n cholera-endemic countries, vaccinating the entire population is not 
warranted. Rather, vaccination should be targeted at high-risk areas and population 
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groups.”213 Finally, “[p]eriodic mass vaccination campaigns are probably the most 
practical option for delivering cholera vaccines.”214 
 
 WHO articulated a different role for cholera vaccines during epidemics. First, 
“[p]reemptive vaccination should be considered by local health authorities to help 
prevent potential outbreaks or the spread of current outbreaks to new areas.”215 Second, 
during large and prolonged epidemics, “reactive vaccination could be considered by local 
health authorities as an additional control measure . . . .”216 Both uses, however, required 
the further development of decisionmaking tools, including risk assessment, and neither 
use should displace a focus on treating individuals who develop the disease and on 
improving water and sanitation.217 
 
 Dukoral (2001) and Shanchol (2011) are WHO prequalified, but mORCVAX is 
not.218 The WHO prequalification program seeks to ensure that medicines, including 
vaccines, purchased through or by international procurement agencies—for example, 
UNICEF or the Global Fund to Fight AIDS—for distribution in resource-limited 
countries meet acceptable standards of quality, safety, and efficacy.219 As a result, 
prequalification status is often critical to a medicine’s  or vaccine’s inclusion in global 
health programs. However, prequalification is not the only consideration. With respect 
to cholera vaccines, for example, Dukoral is more expensive and logistically challenging 
to use than Shanchol220 because it “ha[s] to be drunk with a large glass of buffer solution 
to protect it from stomach acid.”221 Given these impracticalities, Dukoral does not play a 
prominent role in WHO’s recent cholera control programs.222 
 
Two more cholera vaccines have been developed since WHO’s 2010 report. In 
late 2015, WHO prequalified Euvichol, an inactivated oral cholera vaccine developed in 
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the Republic of Korea.223  In 2016, the U.S. Food & Drug Administration (FDA) 
approved a new version of the CVD 103-HgR attenuated virus oral vaccine known as 
Vaxchora.224 Although the FDA granted Vaxchora fast track, priority review, and tropical 
disease priority review225 under the Food, Drug, and Cosmetic Act,226 this new vaccine 
is intended primarily for U.S. residents traveling to other countries.227 Vaxchora is not 
WHO prequalified, and its effectiveness in developing countries has not been 
established.228 
 
 In October 2017, WHO supported the launch of the Global Task Force on Cholera 
Control, a network of United Nations and international agencies, academic institutions, 
and non-governmental organizations committed to reducing world deaths from cholera 
by 90 percent by 2030.229 Oral cholera vaccines are an important component of the Task 
Force’s strategy, particularly in cholera “hot spots,” which include many places in 
Africa.230 In particular, the Task Force advocates the “[l]arge-scale use of [oral cholera 
vaccines] to immediately reduce disease burden while longer-term cholera control 
strategies are put in place.”231 
 
 The Task Force’s reliance on cholera vaccines builds from the July 2013 creation 
of an oral cholera vaccine stockpile and the availability of funding to subsidize the 
vaccine’s cost.232 Overseen by the International Coordinating Group, the goal of the 
stockpile was to make many more doses of cholera vaccines available to countries that 
needed them, particularly during cholera emergencies.233 The stockpile has dramatically 
increased use of cholera vaccines (Shanchol and Euvichol), from 1.4 million doses over 
the 15 years from 1997 to 2012 to 13 million does administered since 2013, mostly during 
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cholera emergencies.234 A record 25 million doses of the vaccines are expected to be 
available in 2018.235 According to the Task Force, this increased availability of oral 
cholera vaccines has become “a game-changer in the fight against cholera. It takes effect 
immediately and also works to prevent cholera locally for two to three years, effectively 
bridging emergency response and longer-term cholera control . . . .”236 Moreover, the 
vaccine is important not only medically but also psychologically, “help[ing] to dispel the 
notion that cholera is inevitable, thereby breaking the vicious cycle of inaction and 
defeatism, motivating national governments and partners, and buying time to implement” 
longer-term cholera control measures such as water supply and sanitation infrastructure 
and hygiene practices.237 
 
 An issue remains, however: Are the cholera vaccines a permanent solution to 
cholera? In 1997, “Vietnam became the first—and so far only—country to provide 
cholera vaccine to its citizens routinely, not just in emergencies.”238 Cholera incidence in 
Vietnam dropped sharply and disappeared from Hue in 2003.239 
 
 Nevertheless, almost all players on the international stage emphasize that cholera 
vaccines, at least in their current form, are an emergency, stop-gap, and/or transitional 
disease control strategy that targets cholera only—a short-term injection of prevention 
and flexibility into cholera control intended to be supplanted by the longer-term and more 
broadly beneficial “no regrets” measures of clean drinking water supplies and effective 
sanitation. Thus, the International Coordinating Group emphasizes that: 
 
The main objective of the oral cholera vaccine stockpile is to ensure the 
timely and targeted deployment of vaccine as part of an effective outbreak 
response. While vaccines provide a short-term effect as an immediate 
intervention to a potential cholera outbreak, expanding access to improved 
drinking-water sources and sanitation is a longer term solution for most 
waterborne diseases, including cholera.240   
 
Similarly, WHO maintains that “[i]n the long term, improvements in water supply, 
sanitation, food safety and community awareness of preventive measures are the best 
means of preventing cholera and other diarrhoeal diseases.”241 
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F. The Ultimate Prevention Strategy: Can We—and Should We—Try to 
Eliminate Epidemic and Pandemic Cholera at the Source? 
 
 The two 2017 Asian-origin papers in Science prompted suggestions that the 
scientific and public health communities should engage in intensive efforts in South and 
East Asia to eliminate the epidemic and pandemic forms of cholera at their source. One 
news story, for instance, emphasized that “the [genomic] research . . . highlights the 
importance of eliminating natural reservoirs of pandemic V. cholerae in Asia. . . . 
Something in the region allows new strains to evolve and spread across the world, and 
scientists aren’t sure what it is.”242 
 
 As with the early warning systems, the proposed strategy of hunting down the 
source of epidemic and pandemic strains of cholera in Asia, particularly South Asia, 
underscores the need for scientists and public health researchers to further elucidate the 
exact relationship between the local reservoir hypothesis and the Asian original 
hypothesis in Bay of Bengal countries. Could it be that something in the Bay of Bengal, 
combined with concentrated populations in India and Bangladesh, is a laboratory for 
cholera pandemics? 
 
 In the mean time, however, many countries need to weigh the costs of a potential 
cholera eradication program—a disease-specific strategy—against the potentially lost 
opportunity to invest in climate-resilient drinking water and sanitation infrastructure and 
the plethora of public health benefits that they bring. If this is the ultimate choice that 
many poor and developing nations face, then the remaining uncertainties surrounding 
cholera etiology and the many co-benefits of climate-resilience water and sanitation 
facilities should weigh strongly in favor of the infrastructure investments. 
 
 
CONCLUSION 
 
 Climate change is already having, and will continue to have for the foreseeable 
future, impacts on human health. Given limited resources, both public health norms and 
strategies for dealing with uncertainty counsel in favor of investment in adaptation 
strategies that provide broad preparedness and prevention advantages, allow for 
additional improvements to human quality of life, fulfill human rights such as the right to 
life and right to water, and help to reduce existing inequalities among populations, 
including inequalities regarding who bears global health burdens. 
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 For all of these reasons, the scientific debate over cholera epidemic etiology 
probably should not, at least for the moment, induce the global health community to re-
think its basic approach to cholera disease control. Increased investment in climate-
resilient drinking water supplies and sanitation facilities remains a “no regrets,” multiple-
benefit public health climate change adaptation strategy and should remain a first priority 
for preventing water-related disease. Where cholera vaccines can bridge a public health 
transition to such infrastructure or prevent the worst scourges of an epidemic, they 
become a helpful supplemental strategy to the primary goal. 
 
 The dream of eradicating cholera epidemics and pandemics creates a compelling 
vision of public health heroism, of science triumphing over another of humanity’s 
microscopic enemies. However, in terms of allocating resources, it should always be 
remembered that clean drinking water and good sanitation facilities are also very 
effective at preventing cholera infections during epidemics and pandemics—and that, in 
addition, they can prevent endemic cholera infection, a host of other water-borne diseases, 
and water-based exposure to toxins, which an Asian eradication strategy would not. At 
least in this instance, therefore, the prosaic public health adaptation strategy should win. 
